News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Genetic markers being used to target oral hepatitis C drug

Please note embargo:

Pharmac_P540c

Genetic markers being used to target new oral hepatitis C drug

A person’s genetic makeup will be used to target a new funded oral treatment for hepatitis C patients from 1 September.

PHARMAC will begin funding boceprevir (Victrelis) from 1 September 2013 for certain patients with the chronic liver infection. Boceprevir will be funded when used as a triple therapy in combination with pegylated interferon with ribavirin.

PHARMAC Medical Director Dr Peter Moodie says many hepatitis C patients do not respond well to current treatments, but that this could improve with the addition of boceprevir.

“Clinical evidence shows that, given the genetic characteristics of a patient, a simple genetic test can fairly accurately predict how they might respond to treatment,” says Dr Moodie.

“There is a group who we know respond poorly to current treatment. They are the ones we think will benefit most from the addition of this new treatment.”

About 25-35% of patients with certain genes showed a sustained response to the currently available treatment of pegylated interferon and ribavirin. By adding boceprevir to the treatment of these patients, the response rate increases to 70–75%.

As well as adding greater effectiveness to available treatments, Dr Moodie says boceprevir is the first funded oral treatment specifically for hepatitis C.

Patients will be genetically tested to determine whether they qualify for boceprevir (in combination with pegylated interferon and ribavirin) as a first-line treatment.

Boceprevir will also be funded for people who have tried but not responded completely to a course of pegylated interferon and ribavirin.

Dr Moodie says though many people live with hepatitis C without ever knowing it, the infection can cause significant health issues including hepatocellular carcinoma, liver failure, which may require a liver transplant.

Pharmacological treatment aims to reduce the likelihood of these transplants being required. In total, PHARMAC expects around 300 patients to start triple therapy in the next year.

In addition to funding boceprevir, PHARMAC has negotiated a price reduction for the Pegasys brand of pegylated interferon with ribavirin. Together, the funding of these hepatitis C treatments will cost $17.8 million over five years, with some of this cost being refunded through confidential rebates negotiated with both suppliers.

ENDS


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

Werewolf: Music Criticism As A Dating Metaphor

Music criticism can be just another form of consumer advic... Yet ever since pop music criticism first entered the media mainstream it has played a wider role, too. Rather than a decree with a numerical score attached, this kind of criticism functions more like travel notes. A conversation, even a form of seduction. More>>

ALSO:

Scoop Review Of Books: Rushing For Gold

The first section focuses particularly on the Victorian connections – commercial, legal, mining and personal, including migration statistics. But for me the most interesting chapters were in the middle sections about the people of the goldfields. More>>

Comedy Festival Review: VOTE BATT

The political campaigning in the US over the last eight months or so has provided a stark insight into how far political candidates are willing to go. This background came into focus as “former comedian” – now politician – Tim Batt ushered people up into the front seats, passing out badges and taking photographs with his not entirely adoring public... More>>

HRH QEII's 90th: New Zealand Post Birthday Stamps Fit For A Queen

New Zealand Post is celebrating the Queen’s 90th birthday with a special series of stamps and a limited edition silver coin. The Queen was born on 21 April 1926. To mark her birthday, New Zealand Post has produced ‘lenticular’ or moving stamps that feature nine different images of the Queen on just three stamps. More>>

ALSO:

Anzac Day: A Time To Stand Against Hatred

The Human Rights Commission says ANZAC Day is a time for New Zealanders to remember those things our grandparents stood for and stand up against intolerance and prejudice. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news